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CPrevention of intravascular catheter infection
Philippe EggimannPurpose of review
To review recent evidence supporting the guidelines for
preventing catheter-related and catheter-associated
infections.
Recent findings
A series of studies has confirmed, over the past few years,
that education-based preventive programmes can reduce
these infections by one half to two thirds. The evidence
supporting some specific measures has increased for the
optimal timing for set replacement, for catheter-site
dressing with chlorhexidine-impregnated devices, and for
the use of some coated or impregnated intravascular
devices.
Summary
Catheter-related and associated infections are largely
preventable and should not be viewed as an unaffordable
tribute to technical medicine. Improvements in existing
techniques and new technologies should all be integrated
into a structured process of continuous improvement in the
quality of care.
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Infections associated with the use of intravascular
catheters or devices represent 10–20% of all nosocomial
infections. They may complicate the stays of up to 10% of
intensive care unit (ICU) patients. Almost all patients
staying in an ICU require at least one intravascular device
for fluid/drug administration and approximately half are
central venous catheters (CVCs) [1]. According to data
from the National Nosocomial Infections Surveillance
system, it is estimated that at least 48 600 ICU patients
develop a CVC-related bloodstream infection every year
in US ICUs (approximately five episodes per 1000
catheter-days). These infections, mostly caused by
coagulase-negative staphylococci, Staphylococcus aureus,
Enterococcus species and Candida species, are associated
with considerable morbidity (prolonged length of stay
and increased costs) and mortality [2]. Although debated
by experts with regard to magnitude, the attributable
mortality of these infections may correspond to 5000–
15 000 deaths directly caused by catheter-related infec-
tions; the benchmarking of rates is currently included in
the assessment of quality of care in many institutions [3].
As for other nosocomial infections, the cornerstone of
prevention of intravascular device-associated or related
infections relies first on a strict observation of the basic
rules of hygiene, of which hand hygiene remains the first
and most important procedure [4]. More specific
measures, including the use of maximal sterile barriers
for insertion, the optimal insertion site, skin preparation,
detailed guidelines for catheter care and replacement,
and defining particular situations in which the use of
antiseptic/antibiotic-coated devices may be used, have
been addressed in many clinical studies, and are exten-
sively discussed in regularly updated evidence-based
guidelines and recommendations [5–7]. A series of
studies has confirmed, over the past few years, that
education-based preventive programmes can reduce
the incidence of these infections by more than two thirds.
Accordingly, infections associated with or related to
intravascular devices are now considered among the most
preventable nosocomial infections, and have become a
focus for the 100 000 Live Campaign of the Institute for
Healthcare Improvement [8].
Prevention of vascular access-associated and
related infections
Recommendations and guidelines for the prevention of
catheter-associated and related infections consisted forrized reproduction of this article is prohibited.
CPrevention of catheter infection Eggimann 361decades of exhaustive catalogues of many specific
measures previously demonstrated to be efficient [5].
Specific measures include the use of maximal sterile
barriers during insertion, optimal insertion site prep-
aration, detailed guidelines for catheter insertion and
replacement, and defining particular situations in which
the use of antiseptic/antibiotic-coated devices may be
useful. Data from surveillance programmes repetitively
showed that they are generally not used or are insuffi-
ciently applied.
As with any nosocomial infections, however, their pre-
vention should rely first on general measures, including
on a strict observation of the basic rules of hygiene, of
which hand hygiene represent the first and most import-
ant procedure [4]. They should be continuously empha-
sized and reinforced before considering any specific
measures [9].
Early in the 2000s four cohort studies showed that multi-
modal educational programmes were able to reduce
dramatically the rate of catheter-associated and related
infections by more than two thirds [10–13]. These pro-
grammes all consisted of the systematic education of the
personnel in charge of the insertion and care of intravas-
cular access in ICUs. Emphasizing general measures first,
including a strict observation of the basic rules of hygiene,
these interventions produced a standardization of care at
the bedside. Elaborated by personnel on the ward in close
collaboration with infection control specialists, and
implemented using communication and education tools,
active participation and positive feedback, they all
resulted in important behavioural changes.
The concept of preventing catheter-related infections
has evolved accordingly, and education-based program-
mes were recommended as a first-line target in the 2002
renewed guidelines for the prevention of intravascular
device-related infections [7].
The objective of this paper is to review further impor-
tant evidence on a series of topics that has appeared
in the literature since the publication of these guide-
lines.
Education-based programmes
Increasing amounts of evidence come from at least 17
additional cohort studies, confirming that when included
in education-based programmes, combined specific
measures can reduce intravascular device-associated and
related infections by one half to two thirds (Table 1)
[14–25,26–30].
In Table 1 the impact of multimodal educational pro-
grammes that target the prevention of intravascular
device-related infections in adult intensive care units,opyright © Lippincott Williams & Wilkins. Unauthbetween 2000–2006 is discussed. The interventions are
catergorized as follows:
Sherertz et al. [10]: Education consisted of one day course
including 1-h stations in which participants received
training in: (1) blood draws through vascular lines;
(2) arterial puncture for obtaining an arterial blood gas;
(3) insertion of arterial catheters and central venous
catheters (CVCs); (4) urinary catheter insertion; (5) lum-
bar puncture; (6) peripheral venous catheter insertion;
(7) phlebotomy.
Eggimann et al. [11]: Multiple-approach intervention
targeted at the reduction of vascular-access infections
including a 30-min slide show and practical demon-
strations completed by individual in-service training.
The programme included detailed written information
on clinical pathways on hand hygiene procedures, for
vascular access insertion, and device maintenance and use.
Yoo et al. [12]: The intervention included: (1) distribution
of new guidelines for the care of catheters (skin and hand
disinfection, occlusive gauze dressing) with insertion sets
that included a sterile gown and gloves, a mask, and a
large sterile drape; (2) daily surveillance in the ICU to
monitor all catheters by a checklist; (3) recommendation
for systematic blood cultures and removal of the catheter
if the patient develops fever of unknown origin or any
symptoms or signs of CR-BSI.
Coopersmith et al. [13]: Based on audits to determined
differences between the Centers for Disease Control and
Prevention (CDC) guidelines and current practice, a task
force built an education intervention to improve practices
related to CVC insertion and care: (1) 10-Page self-study
module with pre and post-question exam including the
following topics: (a) epidemiology and scope of the
problem; (b) risk factors; (c) aetiology; (d) definition;
and (e) methods to decrease risk. Specific risk-reduction
strategies addressed included: (i) handwashing and asep-
tic techniques; (ii) methods for detecting potential
clinical signs and symptoms of local infection; (iii) tech-
niques for sending catheter-tip culture; (iv) routine
catheter site care; (v) replacing administration sets and
fluids; (vi) cleaning and changing injection ports and
luer-lock caps; (vii) how to handle parenteral fluids and
multidose vials; and (viii) procedure for drawing blood
cultures. (2) Guidelines for catheter maintenance
included changing injection caps and intravenous tubing
for fluids and medications every 72 h (or immediately if
blood accumulated in or around the cap or its integrity
was compromised). In addition, transparent line dressings
were replaced every 7 days, whereas gauze dressings
(which were used solely when there was bleeding or
oozing at the insertion site) were changed every 48 h.
The guidelines also recommended that dressings thatorized reproduction of this article is prohibited.
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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immediately.
Warren et al. [14]: Identical to the interventions in
Coopersmith et al. [13].
Zuschneid et al. [15]: The Hospital Infection Surveillance
System (Krankenhaus Infektions Surveillance System;
KISS) uses CDC definitions for reporting in ICUs and
focuses on primary bloodstream infections, urinary tract
infections, pneumonia, and bronchitis. The participating
hospitals receive their rates of infection and device use
twice yearly so as to provide feedback and encourage
infection control activities in the participating ICUs.
Rosenthal et al. [16]: The intervention included three
steps: (1) active surveillance for intravascular device-
associated infections and compliance with intravascular
device site care; (2) education and training of all health-
care workers for catheter care on the basis of the CDC
guidelines; (3) monthly performance feedback docu-
menting rates of compliance with handwashing, gauze
on CVC insertion sites, dates on intravenous adminis-
tration sets, and maintaining the condition of catheter
gauze dressings.
Misset et al. [17]: Implementation of infection control
practices produced by the ICU staff together with the
infection control unit according to the CDC recommen-
dations including general measures such as hand hygiene
and antibiotic control, and specific guidelines targeted at
the prevention of ventilator-associated pneumonia and of
intravascular device-related infections.
Coopersmith et al. [18]: Identical to Coopersmith 2002 [13]
with an additional multifactorial behavioural intervention
targeted at improving compliance deficiencies noted in
audits in intravascular device insertion and maintenance.
Berenholtz et al. [19]: Five components sequentially
introduced from February 1999 to November 2001: (1)
educational intervention to increase provider awareness
of evidence-based infection control practices; (2) creation
of a central catheter insertion cart; (3) asking providers
daily whether catheters can be removed; (4) implementa-
tion of a checklist to be completed by the bedside nurse;
(5) empowerment of nurses to stop procedures if guide-
lines are not followed.
Warren et al. [20]: The intervention included: (1) review
and update of hospital or unit policies and procedures
concerning the insertion and the use of devices by infec-
tion control team and ICU staff and members; (2) staff
education by three methods: (a) didactic lectures and
presentations; (b) self-study module with pre and post-
test; (c) fact sheets and posters; (3) the primary messagesorized reproduction of this article is prohibited.
C364 Nosocomial and hospital-related infectionswere: (i) hand hygiene procedures; (ii) avoidance of
femoral site; (iii) maximal sterile barrier precautions for
insertion; (iv) precise guidelines for catheter handling
and dressing.
Lobo et al. [21]: The intervention consisted of: (1) obser-
vation and 10 pretest questions about hand hygiene and
catheter insertion and handling; (2) education classes and
poster for hand hygiene and catheter insertion (skin
preparation) and handling (dressing replacement).
Wall et al. [22]: The intervention consisted of: (1) edu-
cation: provider, trainee supervision, insertion site, hand
hygiene procedures, skin antisepsis, and use of maximal
sterile barriers; (2) standardized checklist for nurse
including: hand hygiene, trainee supervision, maximal
sterile barriers, skin preparation with chlorhexidine (2%
solution), circumstance of catheter insertion; (3) audits
and monthly feedback.
CDC [23]: The intervention consisted of: (1) education
for catheter insertion practices (maximum sterile barrier
precautions; chlorhexidine solution for skin disinfection;
avoidance of the femoral insertion site; guidelines for
dressing; removal of catheters no longer indicated); (2)
promotion of educational module on device-associated
bloodstream infections and strategies for their preven-
tion; (3) promotion of standardized tools for recording
adherence to recommendations; (4) promotion of a stan-
dardized list of contents for catheter insertion kits; (5)
measurement of CVC-associated bloodstream infection
rates, with quarterly reports allowing anonymous bench-
marking between participating ICUs.
Eggimann et al. [24]: Identical to the interventions in
Eggimann et al. [11].
Higuera et al. [25]: The intervention consisted of: (1)
education: 1 h classes on epidemiology of nosocomial
infections, on hand hygiene, disinfection, on prevention
of intravascular device-associated bloodstream infections,
on prevention of ventilator-associated pneumonia, and on
prevention of catheter-associated urinary tract infections;
(2) performance feedback: monthly chart (hand hygiene
compliance, gauze on CVC insertion sites, dates on
intravenous administration sets, maintenance of gauze
dressings on catheter sites) posted on the walls of the
ICUs; (3) the infection control guidelines included
the introduction of the use alcohol hand-rubs or hand
washing with povidone– iodine soap.
Young et al. [26]: The intervention consisted of: (1)
educational sessions that emphasized the use of maximal
sterile barrier precautions and the use of chlorhexidine
for skin antisepsis during insertion of CVCs; (2) intro-
duction of a special customized CVC kit including a largeopyright © Lippincott Williams & Wilkins. Unauthosterile drape (4100 by 5500 with 400 fenestration) and 2%
chlorhexidine gluconate in 70% isopropyl alcohol for skin
antisepsis.
Tsuchida et al. [27]: The intervention consisted of:
(1) enhanced skin preparation by scrubbing with regular
bathing soap and tap water; (2) a new method for stabil-
ization of the catheter inserted into the internal jugular
vein, in which an additional dressing was placed over the
sterilized dressing; (3) education of the staff for maximal
sterile precautions by teaching staff members and dis-
playing posters; (4) use of a check-list and observation of
catheter insertion by link nurses to monitor compliance;
(5) selection of a disinfectant that requires shorter contact
time and has longer residual effect (from 10% povidone–
iodine to 0.5% chlorhexidine–78% ethanol).
Warren et al. [28]: Identical to the interventions in
Warren et al. [20].
Hatler et al. [29]: The intervention consisted of: (1) staff
members received a one-page document detailing
new strategies to address the prevention of ventilator-
associated pneumonia and CR-BSI, thus increasing their
abilities to control and perform the desired behaviours;
(2) chart of expected activities was posted in each
patient’s room; (3) daily rounds, led by the unit’s nursing
supervisor, helped establish adherence to the targeted
procedures as ‘normal’ behaviour for staff members;
(4) daily goals were posted on white boards in patients’
rooms; (5) regular feedback about the rates; (6) use of a
rapid-cycle approach to increase the flexibility of imple-
menting the change measured for 2–4 weeks.
Pronovost et al. [30]: the intervention included five of
the highly ranked (CDC category IA) evidence-based
recommendations identified as having the greatest effect
on the rate of catheter-related bloodstream infection and
the lowest barriers to implementation [7]. The recom-
mended procedures were: (1) hand washing; (2) using
full-barrier precautions during the insertion of CVCs; (3)
cleaning the skin with chlorhexidine; (4) a subclavian
site is preferred and the femoral site is avoided if possible;
(5) removing unnecessary catheters. They were pro-
moted by local physicians and nurses team leaders as
follows: (a) staff were educated about practices to control
infection and harm resulting from catheter-related blood-
stream infections; (b) central-line cart with necessary
supplies was promoted or created; (c) a checklist was
used to ensure adherence to infection-control practices;
(d) providers were stopped (in non-emergency situations)
if these practices were not being followed; (e) the removal
of catheters was discussed at daily rounds; (f) the teams
received feedback regarding the number and rates of
catheter-related bloodstream infections at monthly and
quarterly meetings, respectively.rized reproduction of this article is prohibited.
CPrevention of catheter infection Eggimann 365The successful prevention of infections has not only been
demonstrated in cases of high initial rates, but also in
institutions with considerable experience in the preven-
tion of nosocomial infections and initially low rates of
infections [10,15,17,18,30]. A majority of these pro-
grammes has been shown to be largely cost-effective.
Moreover, such programmes may also work when
impregnated catheters were already in use before the
intervention [14].
The most recent report concerned an interventional
cohort study involving 103 ICUs in 67 hospitals in
Michigan with more than 375 000 catheter-days of obser-
vation [30]. The intervention, detailed in Table 1, was
remarkable in several points. The programme was pro-
moted by local physicians and nurses organized by team
leaders. It was supported by the introduction of daily goal
sheets to improve clinician-to-clinician communication
within the ICUs. Furthermore, it was integrated in a
comprehensive unit-based safety programme to improve
the safety culture, which also included an intervention to
reduce the incidence of ventilator-associated pneumonia.
Over the 18 months after the implementation of the
intervention, the median rate of catheter-related blood-
stream infections was reduced by 66%, from 2.7 (mean
7.7) to 0 (mean 1.4) per 1000 catheter-days.
The series of mono and multicentre studies, which
includes a large variety of ICUs all around the world,
strongly suggests that the process of training is progress-
ively, and hopefully definitely, moving from the
traditional widespread approach ‘see one, do one, teach
one’ to an integrated and structured process of continuous
improvement of the quality of care.
Optimal timing for intravenous administration
set replacement
The current guidelines recommend, scored with the
highest level of evidence, to replace administration sets,
including secondary sets and add-on devices, no more
frequently than at 72-h intervals, unless a catheter-
related infection is suspected or documented. It is recom-
mended, with a slightly less high level of evidence, to
decrease this delay to 24-h intervals for the adminis-
tration of blood products or lipid emulsions [7].
Gilles et al. [31] from the Cochrane Anesthesia Group
performed a systematic review to identify the optimal
interval for the routine replacement of intravenous admin-
istration sets. From their analysis of the data extracted from
13 out of 23 studies, the authors concluded that adminis-
tration sets that do not contain lipids, blood or blood
products may be left in place for intervals of up to 96 h
without an increase in the risk of infection. There was no
evidence to suggest that administration sets containing
lipids should not be changed every 24 h as currentlyopyright © Lippincott Williams & Wilkins. Unauthrecommended. In addition, subgroup analysis found
no differences between CVCs and peripheral catheters,
nor between participants who did and did not receive
parenteral nutrition, or between children and adults.
Needleless catheter access systems
Designed to reduce the incidence of sharp injuries to
healthcare workers, needleless infusion systems have
been developed by several manufacturers. They have
not been proved to be able to prevent catheter-related
infections, and were scored as an unresolved issue in the
2002 guidelines [7].
Niel-Weisse et al. [32] recently reviewed five random-
ized trials evaluating the effect of vascular access needle-
less closed systems on catheter-related infections among
hospitalized patients. The quality of these trials and the
way they were reported were generally unsatisfactory,
and their heterogeneity did not allow a meta-analysis to
be performed. Nevertheless, there was a trend towards
the needleless closed devices decreasing catheter-related
bloodstream infections. Catheter tip and hub colonization
were significantly reduced in one out of three and two out
of three studies, respectively. From their detailed review,
the authors specified that in contrast to several previous
reports, they did not find a trend in needleless closed
devices towards an increased risk of infection [33,34].
They concluded that there is currently insufficient
evidence to recommend needleless closed vascular
devices, and that new studies are necessary to confirm
that these systems reduce catheter-related infections.
Catheter site dressing with chlorhexidine-impregnated
devices
Gluconate of chlorhexidine is a powerful antimicrobial
agent widely used for surgical scrub and for hand hygiene,
with a good safety profile. When used as a skin disin-
fectant, it is more effective than povidine– iodine
solutions in reducing catheter-related bloodstream infec-
tions [35]. Devices impregnated with chlorhexidine glu-
conate (Biopatch; Ethicon Inc., Somerville, New Jersey,
USA) are able to release it up to 10 days over the skin
surface when placed over the epidural catheter insertion
site [36]. Whether these devices could be routinely used
in the care of short-term intravascular accesses, however,
remained unresolved in the 2002 guidelines [7].
Ho and Litton [37] found 10 prospective, randomized,
controlled clinical trials comparing chlorhexidine-
impregnated dressings with placebo or povidine–iodine
dressing, and included eight of them in a meta-analysis.
The chlorhexidine-impregnated dressing reduced the
risk of intravascular catheter or exit-site colonization
[14.8 versus 26.9%; odds ratio (OR) 0.47; 95% confidence
interval (CI) 0.34–0.65; P< 0.00001]. After excluding
the study that compared chlorhexidine-impregnatedorized reproduction of this article is prohibited.
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associated with a significant reduction in catheter-related
bloodstream infections when compared with placebo
(OR 0.40; 95% CI 0.21–0.75; P¼ 0.004). Local cutaneous
reactions to chlorhexidine-impregnated dressings were
reported in 5.6% of patients in three studies (OR 8.17;
95% CI 1.19–56.14; P¼ 0.04), and 96% of these reactions
occurred in neonatal patients. The number needed to
prevent one episode of bloodstream infection was 142 for
an average period of catheterization of 10 days and a
change of dressings every 5 days. The cost of preventing
one catheter-related bloodstream infection was estimated
to be US$532.5. The authors concluded that the use of
chlorhexidine-impregnated dressings is safe and may be
cost-effective in adult patients with intravascular devices.
This should now be confirmed in a large prospective,
randomized controlled trial.
Coated or impregnated intravascular
devices
The use of antibiotic or antiseptic-impregnated catheters
reduces device-related infections but remains controver-
sial. In the last guidelines, experts recommended con-
sidering the use of such devices if the rate of catheter-
related bloodstream infections remains higher than 3.3
episodes per 1000 CVC-days, after having enhanced
other preventive measures, including multimodal edu-
cative programmes [7].
Several meta-analyses that included studies published
after the release of those guidelines appeared in the
literature.
Walder et al. [38] reviewed the impact of coated devices
in 23 trials, including chlorhexidine–silver sulfadiazine
(CHSS) internal coating in 12, silver-based coating or
cuffing in seven, and various antibiotic coatings in five.
The major finding of that meta-analysis was that in
five trials on CHSS coating (1269 CVCs), in which the
average insertion time ranged from 5.2 to 7.5 days
(median 6 days), the risk of bloodstream infections
significantly decreased from 4.1% in controls to 1.9%
with anti-infective catheters (OR 0.48; 95% CI 0.25–
0.91). In five additional trials on CHSS coating (1544
CVCs), in which the average insertion time ranged
from 7.8 to 20 days (median 12 days), the risk of blood-
stream infections was 4.5% in controls and 4.2% with
anti-infective catheters (OR 0.94; 95% CI 0.58–1.54).
The authors concluded that antibiotic and CHSS coatings
are anti-infective for short insertion times (less than one
week). For longer insertion times (more than one week),
there were no data on antibiotic coating, and some
evidence of a lack of effect for CHSS coating.
Geffers et al. [39] assessed the methodological quality of
11 randomized controlled studies (3131 catheters) withopyright © Lippincott Williams & Wilkins. UnauthoCHSS-impregnated catheters (on their internal surface
only) and the effect on catheter-related infection. The
pooled data did not show a significant reduction of
catheter-related bloodstream infections (OR 0.69; 95%
CI 0.46–1.03). Statistical significance was achieved only
when both studies with a more appropriate type of
definition were separated out (OR 0.58; 95% CI 0.46–
0.96), or when only studies with a short average duration
of catheterization (maximum 8 days) were considered
(OR 0.34; 95% CI 0.15–0.75). The authors highlighted
the fact that all methods of diagnosing catheter coloniza-
tion used in the studies were evaluated with uncoated
catheters. They suggested that failure to use neutralizers
could lead to an underestimation of the rate of catheter-
related bloodstream infections; conversely, the absence
of inhibitory agents may lead to an overestimation of the
antibacterial efficacy of coated catheters.
Falagas et al. [40] performed a meta-analysis of eight
prospective randomized clinical trials including a total of
1715 rifampicin-based impregnated CVCs, 956 uncoated
catheters, 451 catheters coated on their internal surface
by CHSS, and 237 silver–platinum–carbon-impregnated
catheters. Overall, the rifampicin/minocycline-impreg-
nated catheters significantly reduced bacterial coloniza-
tion (OR 0.46; 95% CI 0.31–0.69) and catheter-related
bloodstream infections (OR 0.23; 95% CI 0.14–0.40). On
the basis of the available data, no clear conclusions could
be drawn regarding the impact of the use of rifampicin/
minocycline-impregnated CVCs on the development of
antimicrobial resistance. The authors concluded that
these catheters are safe and effective in reducing the
rate of catheter colonization and related infections.
Regarding the development of resistance, reviewing
the effectiveness and safety of rifampicin-based regimens
in eradicating S. aureus carriage, the same authors
recently concluded that the available evidence suggested
that oral rifampicin is effective in its eradication [41].
They also specified that the development of resistance
occurs in a considerable proportion of patients.
The potential greater efficacy of catheters coated with
minocycline/rifampicin compared with those coated with
CHSS in preventing infections has largely been attrib-
uted to the fact that CHSS coating concerned only the
internal lumen of the device [42]. Since then, a second
generation of CHSS catheters with coating of both the
internal and the external surface was produced by the
manufacturer. At least three studies [43–45], including
two large multicentre ICU studies, have failed to demon-
strate a significant reduction in catheter-related blood-
stream infections. All showed a significant reduction in
bacterial colonization. The overall low rate of infection in
the placebo arms could, however, argue in favour of
insufficient power. By pooling the data, Gastmeier and
Geffers [46] demonstrated a significant reduction in therized reproduction of this article is prohibited.
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risk (RR) 0.40; 95% CI 0.18–0.90].
New composite catheters, consisting of polyurethane
combined with silver, carbon, and platinum, have been
introduced onto the market. They were demonstrated to
be able to release ions of silver with prolonged anti-
microbial activity (oligon) [47–51]. Those studies
showed a significant reduction in bacterial colonization.
Even by pooling the data (822 impregnated versus 833
non-impregnated catheters), Gastmeier and Geffers [46]
did not find a significant reduction in the rate of catheter-
related bloodstream infections (RR 0.81; 0.46–1.45).
To summarize the information of the many randomized
studies, the impact of these devices is in the same range
as those of the educational programmes. Nevertheless,
they should never replace them. It should be highlighted
that in at least one of the studies demonstrating a sig-
nificant reduction in infections after the introduction of a
multimodule educational programme, coated catheters
were used during the entire study period [14].
Borschel et al. [52] recently reported the impact in a
real-world setting after the introduction of CHSS CVCs
(second generation with internal and external coating) in
all consecutive patients requiring central venous access in
six adult ICUs at a large, tertiary care teaching hospital.
The intervention significantly increased the rate of
reduction of the incidence of catheter-related blood-
stream infections by approximately 4% per month, cor-
responding to an overall 35% relative risk reduction over a
16-month period (from approximately nine to less than
four episodes per 1000 device-days). With 41 infections
avoided for approximately 1647 coated catheters inserted,
the authors estimated that the intervention saved
US$266 325 over one year. Assuming that not all of the
observed effect was caused by the coated catheters, the
intervention would remain cost-effective even if only 13%
of the observed decrease in infection rate was attributable
to it. Furthermore, the intervention was associated with a
significant reduction in the rate of vancomycin use.
If such a positive and cost-effective impact of antiseptic-
coated devices in a real-world setting could be confirmed
in large multicentre studies, it may contribute to increase
the level of evidence to include them in all strategies
targeted at the reduction of catheter-related infections.
New areas of development
Antibiotic-lock or flush solutions are not routinely recom-
mended for the prevention of device-related infections
by the 2002 guidelines [7]. They were confirmed to be
able to reduce significantly the rate of catheter-related
infections and be useful in the treatment of persistent
bacteraemia in long-term catheters by two recently pub-opyright © Lippincott Williams & Wilkins. Unauthlished meta-analyses [53,54]. These techniques
should, however, be restricted to this setting when infec-
tion with coagulase-negative staphylococci is documen-
ted but without systemic signs of sepsis or secondary
dissemination [55]. Accordingly, as a result of the risk of
promoting the spread of resistance, and the lack of data in
other types of settings, they should continue not to be
used routinely.
The 2002 guidelines recommend the use of a 2% solution
of chlorhexidine for skin antisepsis before intravascular
device insertion and further maintenance care. The
majority of the commercially available chlorhexidine-
based solutions for use with intravascular devices consist
of 2% chlorhexidine gluconate in 70% isopropyl alcohol.
Medical-grade ethanol has already been in use for many
years for the management or prevention of the occlusion
of intravascular devices used for parenteral nutrition
[56,57]. A series of reports has suggested that 25–70%
of ethanol used as a lock solution may be of value both as
an adjunct to the treatment of intravascular device-
related bloodstream infections and for the prevention
of infection with the use of long-term intravascular
devices [58,59,60]. Crnich and colleagues [61] demon-
strated that a 70% ethanol lock solution has a negligible
impact on the mechanical properties of polyetherur-
ethane and silicone catheters, despite continuous
exposure times as long as 10 weeks. These findings
should prompt further studies of ethanol as an anti-
infective lock solution for the prevention and treatment
of intravascular device-related bloodstream infections in
other settings, including shorter catheterization times.
Conclusion
Catheter-related and associated infections are largely
preventable and should not be viewed as an unaffordable
tribute to technical medicine. Their prevention is a very
active and stimulating field for clinical research. Improve-
ments in many specific technical measures, such as new
catheter securement or fixation devices, will probably
continue to be studied. New technologies are stimulating
the design of new types of impregnated devices. After
being shown to be useful, all these improvements should
then be integrated into structured multimodal edu-
cational programmes. Moreover, these interventions
should all be integrated in a structured process of con-
tinuous improvement of the quality of care.
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